Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY
A Novel Phosphodiesterase Type 4 Inhibitor, YM976 (4-(3-Chlorophenyl)-1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one), with Little Emetogenic Activity
Motonori Aoki, Miki Kobayashi, Jun Ishikawa, Yuji Saita, Yoshiya Terai, Kazuhisa Takayama, Keiji Miyata and Toshimitsu Yamada
Journal of Pharmacology and Experimental Therapeutics October 2000, 295 (1) 255-260;
Motonori Aoki
Miki Kobayashi
Jun Ishikawa
Yuji Saita
Yoshiya Terai
Kazuhisa Takayama
Keiji Miyata
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 295, Issue 1
1 Oct 2000
Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY
A Novel Phosphodiesterase Type 4 Inhibitor, YM976 (4-(3-Chlorophenyl)-1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one), with Little Emetogenic Activity
Motonori Aoki, Miki Kobayashi, Jun Ishikawa, Yuji Saita, Yoshiya Terai, Kazuhisa Takayama, Keiji Miyata and Toshimitsu Yamada
Journal of Pharmacology and Experimental Therapeutics October 1, 2000, 295 (1) 255-260;
Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY
A Novel Phosphodiesterase Type 4 Inhibitor, YM976 (4-(3-Chlorophenyl)-1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one), with Little Emetogenic Activity
Motonori Aoki, Miki Kobayashi, Jun Ishikawa, Yuji Saita, Yoshiya Terai, Kazuhisa Takayama, Keiji Miyata and Toshimitsu Yamada
Journal of Pharmacology and Experimental Therapeutics October 1, 2000, 295 (1) 255-260;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement